C4A.52
Merkel cell carcinoma of skin of breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Merkel cell carcinoma (MCC) is an uncommon but aggressive form of skin cancer that originates in the Merkel cells, which are found in the epidermis, the outermost layer of the skin. When this cancer occurs on the skin of the breast, it requires careful diagnosis and management. MCC of the breast skin is characterized by rapid growth and a tendency to spread to other parts of the body if not detected early.
Causes & Symptoms
Clinical Causes: Immune system suppression, such as in patients with organ transplants or HIV/AIDS Prolonged exposure to ultraviolet (UV) radiation from sunlight or tanning beds Age-related factors, primarily affecting older adults Fair skin that burns easily Previous radiation therapy to the area Presence of the Merkel cell polyomavirus (MCV), which has been linked to many cases
Key Symptoms: Fast-growing, painless nodule or lump on the skin of the breast The lesion is often firm, shiny, and flesh-colored or bluish in appearance Possible ulceration or bleeding from the growth Sometimes the lesion may be mistaken for other benign skin conditions or dermatological issues In advanced cases, symptoms may include swelling or changes in the size or shape of the lesion
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical examination and laboratory testing. A biopsy, where a small tissue sample from the lesion is examined under a microscope, is essential to confirm MCC. Additional tests may include imaging studies such as ultrasound, MRI, or CT scans to determine if the cancer has spread beyond the skin. Immunohistochemical staining can help differentiate MCC from other skin cancers.
Treatment Protocols: Treatment options depend on the size, location, and stage of the tumor. Common approaches include: - Surgical excision to remove the tumor with clear margins - Sentinel lymph node biopsy to assess for spread to nearby lymph nodes - Radiation therapy to target cancer cells and reduce recurrence risk - Chemotherapy or immunotherapy in cases where the disease has spread or is not manageable by surgery and radiation - Regular follow-up and monitoring for signs of recurrence or metastasis Multidisciplinary care involving dermatologists, oncologists, and surgical specialists is often recommended for optimal management.
Clinical Advice & FAQs
Billing Guidance
Is C4A.52 a billable ICD-10 code?
Yes, C4A.52 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C4A.52?
Clinical documentation must specify the nature of Merkel cell carcinoma of skin of breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
